BBLG Live signals | Maximize Profits with Getagraph.com

SELL 105814 min ago

@ $4.66

Issued: 9 Feb 2024 @ 15:44

Return: -65.65%

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 16:00):

Stats
Today's Volume	18 455.00
Average Volume	82 522.00
Market Cap	1.41M
EPS	$0 ( 2024-04-04 )
Next earnings date	( $-7.60 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500
ATR14	$0.0490 (3.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-17	Walsh Deina H	Buy	12 500	Employee Stock Option
2024-01-17	Frelick Jeff	Buy	25 000	Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	8	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Buy	9	Non-Employee Stock Option
2024-01-08	Gagnon Robert E.	Sell	0	Common Stock

INSIDER POWER
32.83
Last 92 transactions
Buy: 61 072 197 \| Sell: 15 856 455

Volume Correlation

Long: -0.01 (neutral)

Short: -0.87 (strong negative)

Signal:(42.365) Neutral

Bone Biologics Correlation

10 Most Positive Correlations
TRKA	0.919
MEUSW	0.877
VYNE	0.874
AUVI	0.873
RMRM	0.868
NMTR	0.865
ACLX	0.859
TGTX	0.857
ELEV	0.857
BTOG	0.851

10 Most Negative Correlations
FINW	-0.896
SLAB	-0.871
EVBG	-0.868
RGCO	-0.864
SITM	-0.862
BPRN	-0.859
CERS	-0.855
COFS	-0.854
ASRVP	-0.851
OESX	-0.85

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bone Biologics Correlation - Currency/Commodity

-0.19
( neutral )

0.26
( neutral )

0.00
( neutral )

-0.48
( neutral )

0.23
( neutral )

-0.70
( moderate negative )

Bone Biologics Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-34.01

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-2.90

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-4.90

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-13.52

Financial Reports:

No articles found.

Bone Biologics

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.